Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04908254 · ClinicalTrials.gov registry record · NA
A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema
A NA study, sponsored by Koya Medical.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04908254 is a NA study that has completed, run by Koya Medical. The registered enrollment target is 50 participants.
The verdict
NCT04908254, a NA study, has completed, sponsored by Koya Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
To evaluate the Dayspring Active Wearable Compression Device in contrast to an advanced pneumatic compression device (APCD)
Interventions
- DEVICE Crossover Device (PCD or Dayspring - alternate to first group)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04908254
The ClinicalTrials.gov registry entry for NCT04908254 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Koya Medical, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Crossover Device (PCD or Dayspring - alternate to first group) is the first listed.
NCT04908254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04908254 about?
NCT04908254 is a clinical study titled "A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema". To evaluate the Dayspring Active Wearable Compression Device in contrast to an advanced pneumatic compression device (APCD)
What is the current status of trial NCT04908254?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-06-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04908254?
The interventions under investigation include: Crossover Device (PCD or Dayspring - alternate to first group) (DEVICE).
Who is sponsoring clinical trial NCT04908254?
This trial is sponsored by Koya Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.